Bevacizumab Injection 400mg/16mL Manufacturer in India | Global Supply for Oncology Medicine Product Highlights Medicine: Bevacizumab Injection Strength: 400mg/16mL Medicine Category: Targeted Biological Therapy Administration: Intravenous Infusion Availability: Hospital & Institutional Supply Only Why Hospitals Choose Bevacizumab Bevacizumab is widely incorporated into modern oncology treatment strategies because it targets the blood vessels that support tumour growth rather than directly attacking cancer cells. It is frequently combined with chemotherapy or other approved treatment regimens according to the patient's diagnosis and clinical condition. Cancer Conditions Where It May Be Used Depending on approved clinical guidelines, Bevacizumab may be selected for treating: ✔ Advanced colorectal cancer ✔ Non-small cell lung cancer ✔ Ovarian cancer ✔ Cervical cancer ✔ Kidney cancer ✔ Brain tumours (glioblastoma) ✔ Liver cancer in approved combination therapy Dosing Principles There is no universal dose for Bevacizumab. The treatment schedule is individualized according to: Patient body weight Type of cancer Combination treatment plan Clinical response Overall health condition Infusions are generally repeated every 2–3 weeks, depending on the oncology protocol. If Treatment Is Delayed Because the medicine is administered in hospitals, patients should contact their oncology department if an appointment cannot be attended. A replacement infusion should only be scheduled by the treating medical team. Patients should never attempt to change the treatment schedule independently. In Case of Excess Administration Administration is supervised by trained healthcare professionals, making overdose uncommon. If a larger quantity than intended is administered, patients may require observation for complications such as elevated blood pressure, bleeding events, or excessive treatment-related toxicity. Management depends on clinical findings and supportive care. Storage & Handling Store according to the manufacturer's recommendations. Keep the vial protected from freezing and excessive heat. Inspect the solution before administration. Use only by trained hospital personnel. Who can purchase Bevacizumab Injection? Licensed hospitals, oncology centres, government institutions, and pharmaceutical distributors. Can Bevacizumab be combined with chemotherapy? Yes. It is commonly used alongside other anticancer medicines according to approved treatment protocols. Is one vial equal to one patient treatment? No. The required quantity depends on the patient's body weight and prescribed treatment regimen. Does Bevacizumab require cold-chain handling? Storage and transport should always follow the manufacturer's approved recommendations. Can international buyers request bulk quotations? Yes. Commercial export quotations are available for qualified pharmaceutical importers and institutional buyers. Bevacizumab Injection Manufacturer India Targeted Cancer Injection Supplier Buy bevacizumab 400 mg 16 ml. Generic Oncology Biologic Exporter VEGF Monoclonal Antibody Supplier Bevacizumab Hospital Procurement Cancer Biologic Distributor Oncology Injection Wholesaler Bevacizumab Bulk Export Pharmaceutical Manufacturer, India Oncology Tender Supplier Biologic Injection Export Company Hospital Cancer Medicine Supplier Anti-VEGF Injection Exporter International Oncology Medicine Supplier 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Distributor | Bulk Supplier | Exporter 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1 #BevacizumabInjection #OncologyBiologics #CancerTherapyDrug #VEGFInhibitor #HospitalCancerCare #BiotechMedicine #PharmaExportsIndia #CancerTreatmentSupply #OncologyDrugSupplier #BiologicTherapy #GlobalPharmaTrade #CancerCareSolutions #MedicalSupplyChain #PharmaceuticalExports #OncologySupport